ARYC
Arrayit Corp Receives Approval for In-Store Promotions by a Major Retail Chain
Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer. Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will collect finger stick blood specimens. Two thousand retail locations nationwide averaging 3,000 customer visits per store per day would give Arrayit access to 6 million retail customers daily, creating the potential for exponential sales growth. This promotional campaign required rigorous vetting and high-level corporate approval by the retailer, which reports revenues exceeding $50 billion annually.
Arrayit recently completed an allergy testing pilot program for a retail chain, established a nationwide network of 1,700 sales professionals to sell and distribute the company’s finger stick microarray tests, met with top officials at the United States Food and Drug Administration (FDA) regarding FDA approval of a major product line, reported the sale of clinical instrumentation to the FDA, and signed allergy testing contracts with a consortium of 178 medical clinics. Doctors can use allergy test results as a guide to prescribe allergy medicines, immunotherapy, food elimination and lifestyle changes. The availability of allergy medicines and immunotherapy products at retail stores, allows customers to incorporate an allergy test into a convenient family shopping experience.
Arrayit CEO Rene Schena states, “Winning approval for in-store promotions by a major US retailer is a significant step in our mission to make allergy testing more convenient and accessible. This program fits nicely into our broader strategy of promoting customer-oriented health and wellness locally and on a national scale.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the research, biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve wellness and human health. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Replies:
This PR was posted on nasdaq.com
ScorpGirl on 8/14/2018 3:30:03 PM
yes we already saw this. Why are you
directmoney on 8/14/2018 3:36:46 PM
Report TOS
:)
All my posts are my opinion only. Please do your due diligence on all your investments.
